Effects of Recombinant Human Growth Hormone Treatment, Depending on the Therapy Start in Different Nutritional Phases in Paediatric Patients with Prader–Willi Syndrome: A Polish Multicentre Study

MLA

Lecka-Ambroziak, Agnieszka, et al. “Effects of Recombinant Human Growth Hormone Treatment, Depending on the Therapy Start in Different Nutritional Phases in Paediatric Patients with Prader–Willi Syndrome: A Polish Multicentre Study.” Journal of Clinical Medicine, July 2021. EBSCOhost, https://doi.org/10.3390/jcm10143176.

APA

Lecka-Ambroziak, A., Wysocka-Mincewicz, M., Doleżal-Ołtarzewska, K., Zygmunt-Górska, A., Wędrychowicz, A., Żak, T., Noczyńska, A., Birkholz-Walerzak, D., Stawerska, R., Hilczer, M., Obara-Moszyńska, M., Rabska-Pietrzak, B., Gołębiowska, E., Dudek, A., Petriczko, E., Szalecki, M., & Treatment, on behalf of the P. C. G. for rhGH. (2021). Effects of Recombinant Human Growth Hormone Treatment, Depending on the Therapy Start in Different Nutritional Phases in Paediatric Patients with Prader–Willi Syndrome: A Polish Multicentre Study. Journal of Clinical Medicine. https://doi.org/10.3390/jcm10143176

Chicago

Lecka-Ambroziak, Agnieszka, Marta Wysocka-Mincewicz, Katarzyna Doleżal-Ołtarzewska, Agata Zygmunt-Górska, Anna Wędrychowicz, Teresa Żak, Anna Noczyńska, et al. 2021. “Effects of Recombinant Human Growth Hormone Treatment, Depending on the Therapy Start in Different Nutritional Phases in Paediatric Patients with Prader–Willi Syndrome: A Polish Multicentre Study.” Journal of Clinical Medicine, July. doi:10.3390/jcm10143176.